देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
CLOZAPINE
SANDOZ CANADA INCORPORATED
N05AH02
CLOZAPINE
100MG
TABLET
CLOZAPINE 100MG
ORAL
100
Prescription
ATYPICAL ANTIPSYCHOTICS
Active ingredient group (AIG) number: 0122583002; AHFS:
CANCELLED PRE MARKET
2022-07-25
_ _ _Sandoz Clozapine Page 1 of 53_ PRODUCT MONOGRAPH PR SANDOZ CLOZAPINE Clozapine Tablets 25 mg and 100 mg tablets Antipsychotic Agent Sandoz Canada Inc. Date of Revision: 110 rue de Lauzon March 20, 2020 Boucherville, QC, Canada J4B 1E6 Control No.: 237094 _ _ _Sandoz Clozapine Page 2 of 53_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................ 3 SUMMARY PRODUCT INFORMATION ........................................................................ 3 INDICATIONS AND CLINICAL USE .............................................................................. 3 CONTRAINDICATIONS ................................................................................................... 5 WARNINGS AND PRECAUTIONS ................................................................................. 5 ADVERSE REACTIONS ................................................................................................. 20 DRUG INTERACTIONS .................................................................................................. 25 DOSAGE AND ADMINISTRATION .............................................................................. 27 OVERDOSAGE ................................................................................................................ 30 ACTION AND CLINICAL PHARMACOLOGY ............................................................ 31 STORAGE AND STABILITY .......................................................................................... 32 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................................. 32 PART II: SCIENTIFIC INFORMATION ............................................................................... 33 PHARMACEUTICAL INFORMATION.......................................................................... 33 CLINICAL TRIALS .......................................................................................................... 34 DETAILED PHARMACOLOGY .................................................. पूरा दस्तावेज़ पढ़ें